Lineage Cell Therapeutics, Inc. · AMEX:LCTX
Chernett Jorey reported a 5.00% stake in Lineage Cell Therapeutics, Inc. (Schedule 13G)
Event Sep 22, 2025 · Filed Sep 26, 2025
Chernett Jorey reported a 5.00% stake in Lineage Cell Therapeutics, Inc., 11,445,003 shares, as a passive investor on Sep 22, 2025. Filed Sep 26, 2025 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 11,445,003
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Chernett Jorey | 5.00% | 11,445,003 |
Source
Related
- Lineage Cell Therapeutics, Inc.
- Chernett Jorey
- Lineage Cell Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13D/A · Neal C. Bradsher · Nov 14, 2025
- Schedule 13G/A · BlackRock, Inc. · Jul 17, 2025
- Schedule 13G · BlackRock, Inc. · Apr 24, 2025
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025